Published in Intern Med on April 01, 2011
Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18)F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review. Case Rep Pulmonol (2014) 0.76
Solitary pulmonary caseating granulomas: A 5-year retrospective single-center analysis. Mol Clin Oncol (2017) 0.75
Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest (2008) 2.68
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis (2013) 2.30
Structural role of countertransport revealed in Ca(2+) pump crystal structure in the absence of Ca(2+). Proc Natl Acad Sci U S A (2005) 2.02
Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol (2010) 1.73
QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups. Scand J Infect Dis (2009) 1.63
Inflammatory pseudotumor of the lung: clinicopathological analysis in seven adult patients. Int J Clin Oncol (2006) 1.55
A case of platypnea orthodeoxia syndrome: a persistent history taking was the key to the diagnosis. Intern Med (2012) 1.48
Mutational analysis of the beta-tubulin gene in lung cancer. Lung Cancer (2002) 1.48
Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma. Ann Thorac Surg (2011) 1.46
Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy. Ann Thorac Surg (2005) 1.41
Usefulness of tuberculin skin test and three interferon-gamma release assays for the differential diagnosis of pulmonary tuberculosis. Intern Med (2012) 1.39
Hermansky-Pudlak syndrome with interstitial pneumonia without mutation of HSP1 gene. Intern Med (2005) 1.39
A small outbreak of pulmonary tuberculosis in non-close contact patrons of a bar. Intern Med (2004) 1.39
Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol (2012) 1.38
The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med (2006) 1.29
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. Cancer Res (2005) 1.28
Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis (2006) 1.26
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med (2006) 1.24
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. Lung Cancer (2005) 1.24
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology (2012) 1.17
Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer. Cancer Lett (2003) 1.15
Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin Cancer Res (2003) 1.15
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother (2013) 1.15
Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol (2007) 1.14
Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit (2008) 1.12
Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect (2008) 1.12
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother (2006) 1.11
Protonation of the acidic residues in the transmembrane cation-binding sites of the ca(2+) pump. J Am Chem Soc (2005) 1.11
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung. Clin Cancer Res (2002) 1.10
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2012) 1.05
Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol (2004) 1.05
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med (2008) 1.04
Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol (2005) 1.03
Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J Infect Chemother (2010) 1.03
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. J Infect Chemother (2011) 1.02
Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. Hum Mol Genet (2006) 1.02
Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol (2010) 1.01
The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Mol Cancer Ther (2004) 1.00
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int J Cancer (2002) 0.98
An indeterminate QuantiFERON TB-2G response for miliary tuberculosis, due to severe pancytopenia. J Infect Chemother (2007) 0.98
Pulmonary mucormycosis (Cunninghamella bertholletiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy. Respirology (2008) 0.97
Clinical evaluation of anaphylactic reactions to intravenous corticosteroids in adult asthmatics. Respiration (2002) 0.97
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int J Cancer (2011) 0.97
Mycobacterium kyorinense infection. Emerg Infect Dis (2013) 0.96
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer (2004) 0.96
Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer (2007) 0.96
Four cases of pulmonary Mycobacterium avium intracellulare complex presenting as a solitary pulmonary nodule and a review of other cases in Japan. Respirology (2006) 0.95
Association of serum arginase I with oxidative stress in a healthy population. Free Radic Res (2010) 0.95
Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells. Int J Cancer (2004) 0.94
Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Intern Med (2007) 0.94
CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice. Eur J Immunol (2011) 0.93
Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients. Int J Cancer (2012) 0.93
Sibling cases of Mycobacterium avium complex disease associated with hematological disease. J Infect Chemother (2006) 0.93
Clinicopathological analysis of multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis in Japan. Respirology (2008) 0.93
Rapid diagnosis of tuberculous pericarditis by ELISPOT assay. Scand J Infect Dis (2010) 0.92
False negative results of QuantiFERON TB-2G test in patients with active tuberculosis. Jpn J Infect Dis (2009) 0.92
Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma. Lung Cancer (2010) 0.92
Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging (2009) 0.92
Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer. Target Oncol (2012) 0.92